Kymera Therapeutics (KYMR) Research & Development (2019 - 2026)
Kymera Therapeutics (KYMR) posted Research & Development of $119.48 million for Q2 2026, up 52.4% from $78.39 million a year earlier and up 21.7% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Research & Development (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Kymera Therapeutics was $375.57 million, up 29.1% year-over-year; for FY2025, it came in at $316.57 million, up 31.8% from FY2024.
- Annual Research & Development has increased for six consecutive years, with a five-year compound annual growth rate of 38.5% (FY2020 to FY2025).
- In prior years, Kymera Therapeutics' Research & Development was $240.25 million in FY2024 (+27.1%), $189.08 million in FY2023 (+15.1%), $164.25 million in FY2022 (+19.9%) and $137.02 million in FY2021 (+120.6%).
- The Q2 2026 figure stands as the highest quarterly Research & Development in data going back to Q3 2019.
- On a year-over-year basis, Research & Development has increased in each of the last 24 quarters, with growth averaging 34.0% over the last eight quarters.
- The year-over-year growth in Research & Development has ranged between 9.7% (Q3 2023) and 142.8% (Q3 2021) over the last five years.
- According to Business Quant data, Research & Development for the three prior quarters was $98.16 million (Q1 2026), $83.83 million (Q4 2025) and $74.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Kymera Therapeutics | 9.27 Bn | 6.58 Bn | - | 119.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 119.48 Mn |
| Mar 31, 2026 | 98.16 Mn |
| Dec 31, 2025 | 83.83 Mn |
| Sep 30, 2025 | 74.09 Mn |
| Jun 30, 2025 | 78.39 Mn |
| Mar 31, 2025 | 80.26 Mn |
| Dec 31, 2024 | 71.82 Mn |
| Sep 30, 2024 | 60.41 Mn |
| Jun 30, 2024 | 59.20 Mn |
| Mar 31, 2024 | 48.82 Mn |
| Dec 31, 2023 | 52.97 Mn |
| Sep 30, 2023 | 48.12 Mn |
| Jun 30, 2023 | 45.77 Mn |
| Mar 31, 2023 | 42.23 Mn |
| Dec 31, 2022 | 43.13 Mn |
| Sep 30, 2022 | 43.88 Mn |
| Jun 30, 2022 | 41.29 Mn |
| Mar 31, 2022 | 35.94 Mn |
| Dec 31, 2021 | 37.53 Mn |
| Sep 30, 2021 | 38.31 Mn |
API Access
Kymera Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();